Biography

         Dr. Perlin has helped establish PHRI as a leading center for research in infectious diseases with a strong emphasis on fundamental, translational and clinical research involving tuberculosis, HIV and other viral, bacterial and fungal pathogens. He was instrumental in the creation of PHRI’s new home at the International Center for Public Health (ICPH), as well as the new Regional Biocontainment Laboratory for the study of acute disease-causing pathogens. Dr. Perlin’s laboratory studies drug resistant fungal infections and rapid diagnosis of opportunistic pathogens in high-risk patients. It is supported by grants from the NIH, Bill and Melinda Gates Foundation, pharma and biotech sectors. Dr. Perlin lectures on the global impact of infectious diseases, especially-drug resistant and hospital-acquired infections, and regularly comments in mainstream media outlets, such as the New York Times. He is on the editorial board of several scientific journals and participates in NIH reviews of grants and contracts. Dr. Perlin serves on the Board of Directors of the Aaron Diamond AIDS Research Center and Scientific/Medical Advisory Boards for Merck, Pfizer, Astellas, Elusys Pharmaceuticals, Inc., Myconostica, LTD, BioDelivery Sciences Int’l., and PinnacleCare. He is also a member of the New York City Department of Health Advisory Panel on Bioterrorism and Emerging Infections, the New York Academy of Sciences Emerging Infectious Diseases Advisory Group, and the Executive Committee of the Northeast Biodefense Center. He serves as director of the PHRI small animal core, as part of the NIH Region II Regional Centers of Excellence in Biodefense and Emerging Pathogens. Most recently, he has worked with the Chinese Academy of Medical Sciences to develop programs on TB and molecular diagnosis of emerging infections in China.

         Dr. Perlin earned an AB degree from Brandeis University in 1976 and a Ph.D. from Cornell University in 1980. He pursued postdoctoral studies at the Yale University School of Medicine and the University of Rochester School of Medicine and Dentistry. Dr. Perlin joined PHRI in 1985; he was named Scientific Director in 1992, President in 2005, and Director of the new PHRI Center in 2006. He was named interim Director of the new $40 million UMDNJ Regional Biocontainment Laboratory. Dr. Perlin was appointed Professor of Microbiology and Molecular Genetics at New Jersey Medical School-UMDNJ in 2003, and was named a Fellow of the New York Academy of Sciences in 2005.



To download a pdf copy of Dr. Perlin's Biography, please follow this link.